| Central Nervous System Agents for Ischemic Stroke: Neuroprotection Mechanisms. | |
| | |
MedLine Citation:
|
PMID: 21521165 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Stroke is the third leading cause of mortality and disability in the United States. Ischemic stroke constitutes 85% of all stroke cases. However, no effective treatment has been found to prevent damage to the brain in such cases except tissue plasminogen activator with narrow therapeutic window, and there is an unmet need to develop therapeutics for neuroprotection from ischemic stroke. Studies have shown that mechanisms including apoptosis, necrosis, inflammation, immune modulation, and oxidative stress and mediators such as excitatory amino acids, nitric oxide, inflammatory mediators, neurotransmitters, reactive oxygen species, and withdrawal of trophic factors may lead to the development of the ischemic cascade. Hence, it is essential to develop neuroprotective agents targeting either the mechanisms or the mediators leading to development of ischemic stroke. This review focuses on central nervous system agents targeting these biochemical pathways and mediators of ischemic stroke, mainly those that counteract apoptosis, inflammation, and oxidation, and well as glutamate inhibitors which have been shown to provide neuroprotection in experimental animals. All these agents have been shown to improve neurological outcome after ischemic insult in experimental animals in vivo, organotypic brain slice/acute slice ex vivo, and cell cultures in vitro and may therefore aid in preventing long-term morbidity and mortality associated with ischemic stroke. |
| | |
Authors:
|
Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang |
Related Documents
:
|
14704895 - A review of the influence of aqueous humor on immunity. 21503695 - Clinical assessment and management of cytopenias in lupus patients. 17404295 - Myd88 is required for the formation of long-term humoral immunity to virus infection. 1663995 - Effects of vancomycin, teicoplanin, daptomycin and coumermycin on normal immune capabil... 18434235 - Airway epithelial cell inflammatory signalling in cystic fibrosis. 21472345 - Anti-apoptotic effect of activated protein c on lipopolysaccharide-stimulated human umb... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-27 |
Journal Detail:
|
Title: Central nervous system agents in medicinal chemistry Volume: - ISSN: 1875-6166 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101269163 Medline TA: Cent Nerv Syst Agents Med Chem Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. xwang@rics.bwh.harvard.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evidence-Based Medicine Update on Testosterone Replacement Therapy (TRT) in Male Hypogonadism: Focus...
Next Document: From Bone to Brain: Human Skeletal Stem Cell Therapy for Stroke.